The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1965, 94: 371-378.
Copyright © 1965 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paucker, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paucker, K.

The Serologic Specificity of Interferon1

Kurt Paucker

From the Virus Laboratories at Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine

Abstract

An improved method for the titration of antibodies against interferon has been described. The assay permits the use of 10 to 15 times less interferon for neutralization by antibody than conventional monolayer techniques. Neutralizing titers of anti-interferon sera are enhanced by a corresponding factor. Reading of the test is based on color change of the phenol red indicator in the medium, which can be recorded visually or in a photoelectric colorimeter. The assay has been used with L, HeLa and chick embryo fibroblast cells.

Antibodies against L cell interferon developed in guinea pigs only after a prolonged course of immunization. Similar results were obtained in rabbits injected with L interferon and in guinea pigs immunized with chick interferon. HeLa interferon of low potency failed to elicit antibodies.

Neutralization tests with anti-interferon sera disclosed that a) L interferon differs antigenically from the producer cell, b) L, chick and HeLa interferons posses different antigenic compositions and c) minor cross-protection of heterologous cells may be due to components in the preparations other than interferon.

Footnotes

1 This work has been supported by Grant AI-02405 from the National Institutes of Health, United States Public Health Service.

A portion of this report was presented at the International Symposium on Nonspecific Resistance to Virus Infection, Interferon and Viral Chemotherapy, Smolenice, Czechoslovakia, September 1964.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1965 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1965 by The American Association of Immunologists, Inc. All rights reserved.